GlassScriptPhysician profile
Murray N Ehrinpreis
NPI 1972540979
$1,798.80
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $306 · 2021: $418 · 2022: $228.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $659.38 | 2019-2022 | |
| Gilead Sciences, INC. | $397.55 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $209.53 | 2019-2022 | |
| Pfizer INC. | $89.09 | 2019-2020 | |
| Janssen Biotech, INC. | $73.51 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $73.30 | 2019 | |
| Celgene Corporation | $48.76 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.54 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $39.30 | 2021-2022 | |
| Dynavax Technologies Corporation | $30.12 | 2019 | |
| Intercept Pharmaceuticals, INC. | $26.70 | 2019 | |
| Ardelyx, INC. | $24.23 | 2022 | |
| Sobi, INC | $18.35 | 2020 | |
| Ucb, INC. | $18.16 | 2019 | |
| Qol Medical, LLC | $17.69 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.14 | 2019 | |
| Shionogi INC | $12.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Ehrinpreis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.